Synthesis and anticancer evaluation of naphthoquinone esters with 2′-cyclopentyl and 2′-cyclohexyl substituents

Bioscience, Biotechnology and Biochemistry

Volumn 74, Issue 6, 2010, Pages 1205-1214

  Kongkathip, Ngampong ^a   Pradidphol, Narathip ^a   Hasitapan, Komkrit ^a   Kongkathip, Boonsong ^a  

^a KASETSART UNIVERSITY   (Thailand)

Author keywords

Cancer cell lines; Cytotoxicity; Naphthoquinone ester; Rhinacanlhin derivative

Indexed keywords

1-HYDROXY-2-NAPHTHOIC ACID; CANCER CELL LINES; CERVICAL CARCINOMA; CYCLOHEXYL; CYCLOHEXYL ESTER; DIMETHYL GROUPS; HEPATOCELLULAR CARCINOMA; HUMAN EPIDERMOID CARCINOMA; NAPHTHOQUINONE; NAPHTHOQUINONE ESTER; PROPYL CHAIN; RHINACANLHIN DERIVATIVE; STRONGER ACTIVITIES;

CELL CULTURE; CELLS; CYTOTOXICITY; ESTERIFICATION; HYDROCARBONS; KETONES;

ESTERS;

ANTINEOPLASTIC AGENT; CYCLOHEXANE; CYCLOHEXANE DERIVATIVE; CYCLOPENTANE DERIVATIVE; ESTER; NAPHTHOQUINONE;

ARTICLE; CHEMISTRY; HUMAN; IC 50; SYNTHESIS; TUMOR CELL LINE; IC50;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CYCLOHEXANES; CYCLOPENTANES; ESTERS; HUMANS; INHIBITORY CONCENTRATION 50; NAPHTHOQUINONES;

EID: 77953987672     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.90946     Document Type: Article

References (12)

1. Kongkathip N, Luangkamin S, Kongkathip B, Sangma C, Grigg R. Kongsaevee P. Prabpai S. Pradidphol N, Piyaviriyagul S.and Siripong P, J. Med. Chem, , 47, 4427-4438 (2004).
2. Kongkathip N, Kongkathip B, Siripong P, Sangma C, Luangkamin S, Niyomdecha M. Pattanapa S. Piyaviriyagul S, and Kongsaeree P, Bioorg. Med. Chem., 11, 3179-3191 (2003).
3. Wu TS, Hsu HC, Wu PL, Leu YL, Chan YY, Chern CY, Yeh MY, and Tien HJ, chem. Pharm. Bull., 46, 413-418 (1998).
4. Wu TS, Hsu HC, Wu PL, Teng CM, and Wu YC, Phytochemistry, 49, 2001-2003 (1998).
5. Kuwahara S, Awai N, and Kodama O, J. Nat. Prod., 58, 1455-1458 (1995).
6. Rojanapo W, Tepsuwan A, and Siripong P, Basic Life Sci., 52, 447-452 ( 1990).
7. Kupradinun P, Siripong P, Chanpai R, Piyaviriyagul S, Rungsipipat A, and Wangnaitham S, Asian Pac. J. Cancer Prev., 10, 103-106 (2009).
8. Siripong P. Yahuafai J. Shimizu K, Ichikawa K. Yonezawa S, Asai T. Kanokmedakul K. Ruchirawat S. and Oku N, Biol. Pharm Bull., 29, 2279-2283 (2006).
9. Siripong P, Hahnvajanawong C. Yahuafai J. Piyaviriyakul S, Kanokmedhakul K. Kongkathip N. Ruchirawat S. and Oku N, Biol. Pharm. Bull., 32, 1251-1260 ( 2009).
10. Siripong P, Yahuafai J, Shimizu K, Ichikawa K. Yonezawa S. Asai T, Kanokmedhakul K. Ruchirawat S, and Oku N, Biol. Pharm Bull., 29, 2070-2076 (2006).
11. Zimmer H, Lankin DC, and Horgan SW, Chem. Rev., 71, 229-246 (1971).
12. Skehan P, Storeng R. Scudiero D. Monko A. McMahon J. Vistica D, Warren JT, Bokesch H, Kenncy S, and Boyd MR. J. Natl. Cancer Inst.. 82. 1107-1112 ( 1990).